Stock listing

NASDAQ:COGT Cogent Biosciences, Inc. Stock

Home listing (NASDAQ) of Cogent Biosciences, Inc.

Follow Cogent Biosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:COGT

$27.81 USD -0.04 (-0.1%)

Close on Nov 18, 2026

Past year -16.7% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
$27.73 – $28.77 USDNov 18, 2026
Volume
2.71M sharesNov 18, 2026
Market cap
$4.84B USDAt the close on Nov 18, 2026 · price × 174.0M shares outstanding
52-week range
$26.36 – $43.73 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
$65.06M USDMedian day 1.87M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026
Cogent Biosciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:COGT · Home$27.81 USD-0.04 (-0.1%)2,711,457$27.81$28.77$27.73$27.85Close on Nov 18, 2026

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:COGT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$27.81-0.04-0.1%$27.81$28.77$27.732,711,457
$27.85+0.41+1.5%$27.22$28.08$26.363,363,427
$27.44-1.12-3.9%$28.71$28.81$27.231,449,161
$28.56-0.58-2.0%$29.01$29.02$28.451,150,715
$29.14-0.26-0.9%$29.01$29.78$28.611,858,718
$29.40-2.24-7.1%$31.93$32.33$28.804,513,711
$31.64-1.90-5.7%$33.21$33.65$31.602,850,312
$33.54+1.895+6.0%$32.38$34.04$31.491,689,876
$31.65+2.065+7.0%$29.53$31.69$28.971,481,731
$29.58-1.91-6.1%$31.34$31.41$29.162,724,932
$31.49+0.43+1.4%$32.03$32.03$29.942,229,450
$31.06+1.33+4.5%$30.08$31.27$30.061,876,714
$29.73-1.29-4.2%$31.31$31.48$29.691,998,106
$31.02-0.94-2.9%$31.75$32.34$30.652,495,131
$31.96-0.27-0.8%$32.86$32.86$31.681,507,387
$32.23+0.22+0.7%$31.77$32.68$31.681,740,882
$32.01+1.10+3.6%$31.10$32.22$30.721,838,062
$30.91-0.30-1.0%$31.41$31.55$30.522,205,980
$31.21-0.10-0.3%$30.94$31.27$30.331,771,236
$31.31-0.12-0.4%$31.07$31.91$30.861,178,296
$31.43+0.19+0.6%$31.26$31.94$31.202,099,781
$31.24+1.23+4.1%$30.24$31.50$30.032,311,787
$30.01+0.49+1.7%$29.66$30.23$29.512,541,218
$29.52+0.010.0%$29.47$29.98$28.772,783,048
$29.51+1.36+4.8%$28.33$29.78$28.333,039,765
$28.15+0.06+0.2%$27.93$29.05$27.742,295,507
$28.09-1.69-5.7%$29.46$29.46$27.852,995,450
$29.78-1.22-3.9%$30.81$31.07$29.631,855,295
$31.00+0.92+3.1%$29.98$31.03$29.902,522,272
$30.08-0.06-0.2%$29.71$30.66$28.693,643,985
$30.14-0.24-0.8%$30.05$30.43$29.881,262,894
$30.38-0.49-1.6%$31.17$31.17$29.702,383,802
$30.87-0.15-0.5%$31.26$31.37$29.931,792,883
$31.02-0.57-1.8%$32.12$32.29$30.861,172,134
$31.59-0.43-1.3%$32.02$32.57$31.521,698,630
$32.02+0.36+1.1%$31.74$32.76$31.491,960,172
$31.66-0.20-0.6%$31.76$32.12$31.321,704,731
$31.86-0.45-1.4%$32.00$32.20$31.232,212,923
$32.31+0.88+2.8%$31.55$32.71$31.052,979,048
$31.43+0.02+0.1%$31.21$31.95$30.352,591,471
$31.41-1.22-3.7%$32.62$32.85$30.882,330,314
$32.63+0.63+2.0%$32.23$32.85$32.062,036,175
$32.00+0.50+1.6%$31.97$32.52$31.413,415,438
$31.50-1.69-5.1%$33.21$33.42$31.394,604,077
$33.19+0.65+2.0%$33.07$33.64$32.881,189,539
$32.54-0.20-0.6%$32.89$33.27$32.201,921,689
$32.74-0.67-2.0%$33.37$33.93$32.691,712,424
$33.410.000.0%$33.42$33.58$32.851,437,396
$33.41-0.67-2.0%$34.51$35.00$33.211,715,802
$34.08-0.10-0.3%$33.50$34.19$33.072,264,643
$34.18-1.10-3.1%$35.09$35.57$34.081,587,526
$35.28+0.52+1.5%$34.16$35.75$33.902,244,424
$34.76-0.19-0.5%$34.56$35.20$34.42784,080
$34.95+0.38+1.1%$34.90$35.14$34.061,268,646
$34.57-0.11-0.3%$35.18$35.82$34.011,181,784
$34.68-0.32-0.9%$34.48$34.99$34.301,480,641
$35.00+0.33+1.0%$34.61$35.21$34.111,849,678
$34.67-2.42-6.5%$36.66$36.85$34.531,771,221
$37.09+0.37+1.0%$36.51$37.67$36.411,636,565
$36.72-0.08-0.2%$36.49$37.12$36.281,062,781
$36.80+0.57+1.6%$36.56$37.08$36.441,394,407
$36.23-0.50-1.4%$36.75$37.12$36.071,214,545
$36.73+1.42+4.0%$35.75$37.22$35.402,515,752
$35.31-1.54-4.2%$36.31$36.70$34.911,943,841
$36.85-0.55-1.5%$38.62$38.62$36.701,249,799
$37.40-0.47-1.2%$37.32$38.31$37.011,151,059

Splits

1 split · NASDAQ:COGT · every price before a split is adjusted for it

DayRatioWhat
1-for-4Consolidation
Ticker
NASDAQ:COGT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Cogent Biosciences, Inc. news

Financings

  • At-the-market programme of shares

    Aug 10, 2026

    Closed: US$73.6M raised

    Use of proceeds: Fund operating expenses and capital expenditures into late 2028, including through potential FDA approvals of bezuclastinib and early commercial launch

    Closed Aug 10, 2026

  • 1.625% convertible senior notes due 2031

    Nov 11, 2025

    Update: US$200M · Jefferies +1

    Dealers: Jefferies (co-lead), J.P. Morgan (co-lead)

    Use of proceeds: Repay $50 million of term loans; bezuclastinib development, regulatory work and commercial launch; other candidates; working capital and general purposes

    Announced Nov 10, 2025 · Update Nov 11, 2025

  • Public offering of shares of common stock

    Nov 11, 2025

    Made bigger: US$200M · US$31 a share · J.P. Morgan +5

    Dealers: J.P. Morgan (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Raymond James

    Use of proceeds: Repay $50 million of term loans; bezuclastinib development, regulatory work and commercial launch; other candidates; working capital and general purposes

    Announced Nov 10, 2025 · Made bigger Nov 11, 2025

  • At-the-market programme of shares of common stock

    Nov 3, 2025

    Closed: US$39M raised

    Closed Nov 3, 2025

  • Public offering of shares of common stock

    Jul 10, 2025

    Closed: US$230M raised · US$9 a share · J.P. Morgan +3

    Dealers: J.P. Morgan (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead), LifeSci Capital

    Use of proceeds: Development, regulatory and commercial preparation for bezuclastinib and other candidates, its commercial launch, working capital and general corporate purposes

    Made bigger Jul 8, 2025 · Announced Jul 8, 2025 · Closed Jul 10, 2025

  • At-the-market programme of common stock

    Feb 25, 2025

    Closed: US$25M raised

    Closed Feb 25, 2025

Read by 6ix AI from the company's releases

Decks

Cogent Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
26 in the last 12 months · 150 in all · newest Nov 5, 2026 · oldest 2019
Decks
17 decks · latest September 2026

Where Cogent Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:COGT · Home listing · This pageNASDAQUnited StatesUSD
BX Swiss:COGTBX SwissSwitzerlandCHF
BOATS:COGTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Cogent Biosciences, Inc.